Back to search
FDAFDA · Food and drugs·Recall number D-0078-2018

Lumigan (bimatoprost ophthalmic solution) 0.01%, 2.5 mL bottle, Rx only, Allergan, Irvine, CA 92612. NDC# 0023-3205-03

Published November 22, 2017 · Recall initiated: October 19, 2017

Summary

FDA records drug Class III recall D-0078-2018, published November 22, 2017 and initiated October 19, 2017. Recalling firm: Allergan Sales, LLC; Status: Terminated; Reported quantity: 153,616 bottles; Lot: Lot #: 92575 Exp. JUN-2018. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Impurities/Degradation Specifications.

What to do

Voluntary: Firm initiated · Letter

Get an email if LUMIGAN has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
LUMIGAN
Manufacturer
Allergan Sales, LLC
Distributor
Nationwide and Barbados, Curacao, Dominican Republic, Guyana, Jamaica, and Trinidad and Tobago.
Lot
Lot #: 92575 Exp. JUN-2018
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Lumigan (bimatoprost ophthalmic solution) 0.01%, 2.5 mL bottle, Rx only, Allergan, Irvine, CA 92612. NDC# 0023-3205-03 recalled?

Yes. FDA published recall D-0078-2018 on November 22, 2017. Reported hazard: Failed Impurities/Degradation Specifications.

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: LUMIGAN.